Better COVID-19 Stock: Merck or Pfizer?

Better COVID-19 Stock: Merck or Pfizer?
·4 min read

Pfizer (NYSE: PFE) launched the best-selling vaccine Comirnaty with the help of its partner, BioNTech. Merck (NYSE: MRK) is likely to soon have the first COVID-19 pill on the market. Pfizer has delivered greater stock gains than Merck since the beginning of the pandemic.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting